banner

Across Health to hold first iD.cast webcast ‘Digital Acceleration in Biopharma’ on 15 October

October 2, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, event

Across Health is hosting its first iD.cast webcast, titled Digital Acceleration in Biopharma on 15 October. This ninety-minute webinar online …

vaccination-1215279_960_720

IGT Biologika’s COVID-19 vaccine becomes third in Germany to be approved for human trials

October 2, 2020
Medical Communications, Research and Development COVID-19, IDT Biologika, Vaccine

German biotech IDT Biologika has become the third company in the country to secure approval from the nation’s vaccine regulator …

800px-astrazeneca_hq_in_cambridge_uk_1

AstraZeneca’s COVID-19 vaccine trials resume in Japan but still on hold in US

October 2, 2020
Medical Communications COVID, coronavirus

AstraZeneca’s experimental coronavirus vaccine has resumed clinical trials in Japan after a patient illness halted the global study, but the …

donald_and_melania_trump

Donald and Melania Trump test positive for COVID-19

October 2, 2020
Medical Communications COVID-19, Trump, coronavirus

President Donald Trump and First Lady Melania Trump have both tested positive for COVID-19.  Trump tweeted: “Tonight, @FLOTUS and I …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 2, 2020
Medical Communications

The top ten news stories this week focus on vaccines and treatments, with allegations Russia is sowing disinformation about COVID-19 …

novartis_outside_1

Novartis unveils strong Phase 3 efficacy for one-time therapy Zolgensma in paediatric spinal muscular atrophy

October 1, 2020
Research and Development Novartis, Zolgensma, spinal muscular atrophy

Novartis has lifted the curtain on new Phase 3 data from an ongoing trial of 33 participants on the efficacy …

shutterstock_38078521

Enlivex’s Allocetra improves COVID-19 recovery times, early data show

October 1, 2020
Research and Development Allocetra, Enlivex

Israeli immunotherapy firm Enlivex Therapeutics has released tentatively positive data for its therapy Allocetra as a treatment for patients with …

800px-healthcare_workers_wearing_ppe_03

Coronavirus transmission in India driven by superspreaders

October 1, 2020
Research and Development

India’s largest contract tracing study has found that the virus has been transmitted through ‘super spreaders.’ The study was conducted …

backlit_keyboard

Russia is spreading lies about COVID-19 vaccines, alleges UK Chief of Defence Staff

October 1, 2020
Research and Development Hackers, Russia, Russians, coronavirus vaccine

Russia is sowing disinformation about COVID-19 vaccines to undermine inoculation efforts in Western aligned countries, according to a top UK …

800px-library_of_congress_open_house_2182091

High US drug prices driven by profits, House Oversight Committee report finds

October 1, 2020
Research and Development

The rising cost of US drugs are primarily driven by the pursuit of profit by pharmaceutical companies, according to an …

nice_new_london_office_internal_3_web

NICE gives go-ahead for Sandoz’s Rizmoic to treat opioid-induced constipation

September 30, 2020
Research and Development, Sales and Marketing NHS, NICE, Rizmoic, Sandoz, UK

The National Institute for Health and Care Excellence (NICE) has recommended Sandoz’s Rizmoic (naldemedine) for the treatment of opioid-induced constipation …

bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

September 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …

800px-a_tamiflu_oseltamivir_capsule

Judge allows $1.5 billion Tamiflu stockpiling lawsuit against Roche to go ahead

September 30, 2020
Research and Development Roche, Tamiflu

A Maryland federal judge denied Roche’s motion to throw out a lawsuit that alleges the company defrauded the US and …

amoeba

Brain-eating amoeba in Texas water supply kills six-year-old

September 30, 2020
Research and Development amoeba, brain eating ameoba

Officials in Texas have said it could take two to three months to disinfect the water supply in Lake Jackson …

covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The coronavirus news this week focuses on the development of treatments to alleviate symptoms of the virus, as Australian biotech …

reblozyl

Canadian approval for Reblozyl for transfusion-dependent anaemia in beta-thalassemia patients

September 29, 2020
Manufacturing and Production, Sales and Marketing BMS, Canada, Reblozyl

Bristol Myers Squibb and Acceleron have managed to secure regulatory approval in Canada for Reblozyl (luspatercept) for the treatment of …

800px-pfizer_finland_hq_february_13_2009_1

Pfizer’s Xeljanz approved by the FDA for the treatment of children with arthritis

September 29, 2020
Manufacturing and Production

The FDA has approved Pfizer’s Xeljanz (tofacitinib) for the treatment of children and adolescents with active polyarticular course juvenile idiopathic …

president_of_the_united_states_donald_j

Trump announces 150 million Abbott COVID-19 tests will be deployed across the US

September 29, 2020
Manufacturing and Production

President Donald Trump announced on Monday that the government will distribute 150 million coronavirus tests from Abbott Laboratories across the …

fda_21_4

FDA pauses the planning stages of Inovio’s late-stage COVID-19 vaccine trials

September 29, 2020
Manufacturing and Production COVID-19 vaccine, FDA, coronavirus vaccines

The FDA has put Inovio’s planning stages for the final trials of its coronavirus vaccine on hold as the regulator …

The Gateway to Local Adoption Series

Latest content